Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1690793rdf:typepubmed:Citationlld:pubmed
pubmed-article:1690793lifeskim:mentionsumls-concept:C0022688lld:lifeskim
pubmed-article:1690793lifeskim:mentionsumls-concept:C0079722lld:lifeskim
pubmed-article:1690793lifeskim:mentionsumls-concept:C1334240lld:lifeskim
pubmed-article:1690793lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:1690793lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:1690793lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:1690793pubmed:issue4lld:pubmed
pubmed-article:1690793pubmed:dateCreated1990-4-30lld:pubmed
pubmed-article:1690793pubmed:abstractTextA monoclonal antibody against the surface marker IOT-10 of natural killer (NK) cells was used to investigate the presence and distribution of these cells in a series of nine primary intracranial germinomas. In all of these tumors, IOT-10-positive NK cells were found in small numbers, mainly distributed among the tumor cells. The data obtained in the present study suggest that the presence of NK cells in primary intracranial germinomas can be influenced by factors other than the mere quantity of tumor-infiltrating lymphocytes.lld:pubmed
pubmed-article:1690793pubmed:languageenglld:pubmed
pubmed-article:1690793pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1690793pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1690793pubmed:statusMEDLINElld:pubmed
pubmed-article:1690793pubmed:monthAprlld:pubmed
pubmed-article:1690793pubmed:issn0022-3085lld:pubmed
pubmed-article:1690793pubmed:authorpubmed-author:VaqueroJJlld:pubmed
pubmed-article:1690793pubmed:authorpubmed-author:CocoAAlld:pubmed
pubmed-article:1690793pubmed:authorpubmed-author:MartinezRRlld:pubmed
pubmed-article:1690793pubmed:authorpubmed-author:MagallónRRlld:pubmed
pubmed-article:1690793pubmed:authorpubmed-author:PontónPPlld:pubmed
pubmed-article:1690793pubmed:issnTypePrintlld:pubmed
pubmed-article:1690793pubmed:volume72lld:pubmed
pubmed-article:1690793pubmed:ownerNLMlld:pubmed
pubmed-article:1690793pubmed:authorsCompleteYlld:pubmed
pubmed-article:1690793pubmed:pagination616-8lld:pubmed
pubmed-article:1690793pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:meshHeadingpubmed-meshheading:1690793-...lld:pubmed
pubmed-article:1690793pubmed:year1990lld:pubmed
pubmed-article:1690793pubmed:articleTitleImmunohistochemical study of natural killer cells in tumor-infiltrating lymphocytes of primary intracranial germinomas.lld:pubmed
pubmed-article:1690793pubmed:affiliationDepartment of Neurosurgery, Puerta de Hierro Clinic, Autonomous University, Madrid, Spain.lld:pubmed
pubmed-article:1690793pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1690793pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed